HIV infected macrophages isolated from HIV plus patients with undetectable viral load undergoing highly active antiretroviral therapy.

被引:0
|
作者
Belmonte, L [1 ]
Bare, P [1 ]
Corti, M [1 ]
Bracco, MM [1 ]
Ruibal-Ares, B [1 ]
机构
[1] Acad Nacl Med, Inst Invest Hematol, RA-1425 Buenos Aires, DF, Argentina
关键词
macrophages; HIV; HAART;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A new method of culture of peripheral blood leukocytes (PBMC) from HIV+ patients, in the absence of exogenous stimuli (allogeneic cells or cytokines) (PBMC w/s) was used for the detection of persistent viral infection in HIV patients who had undergone successful highly active antiretroviral therapy (HAART) lowering their viral burden to undetectable levels (< 50 RNA copies/ml). Infected cells were always of the monocyte/macrophage lineage (M). No infection could be detected in these patients using the classical system (co-culture with HIV-CMP activated with PHA and IL-2). Differences in the class of target cells (higher proportion of proliferating M and CCR5 expressing cells in the PBMC w/s system than in PBMC-PHA cultures) may determine the relative sensitivity of each technique to achieve successful isolation of HIV from different patients.
引用
收藏
页码:73 / 75
页数:3
相关论文
共 50 条
  • [1] Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women
    Patel, Deven
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (12) : 1647 - 1656
  • [2] Gender differences for frailty in HIV-infected patients on stable antiretroviral therapy and with an undetectable viral load
    Blanco, Jose-Ramon
    Barrio, Inmaculada
    Ramalle-Gomara, Enrique
    Isabel Beltran, Maria
    Ibarra, Valvanera
    Metola, Luis
    Sanz, Mercedes
    Oteo, Jose A.
    Melus, Estrella
    Anton, Lucia
    [J]. PLOS ONE, 2019, 14 (05):
  • [3] Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy.
    Bozzette, SA
    Joyce, G
    McCaffrey, DF
    Leibowitz, AA
    Morton, SC
    Berry, SH
    Rastegar, A
    Timberlake, D
    Shapiro, MF
    Goldman, DP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11): : 817 - 823
  • [4] Langerhans cells in periodontal disease of HIV- and HIV plus patients undergoing highly active antiretroviral therapy
    Segundo, Takeshi Kato
    Sauto, Giovanna Ribeiro
    Mesquita, Ricardo Alves
    Costa, Fernando Oliveira
    [J]. BRAZILIAN ORAL RESEARCH, 2011, 25 (03): : 255 - 260
  • [5] Outcome of HIV-1 infected patients with high viral load treated with combination antiretroviral therapy.
    Vande Waa, JA
    Vande Waa, EA
    Hoff, CJ
    Ramsey, KM
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 14A - 14A
  • [6] Undetectable HIV-1 viral load in the fluid of bullous skin lesion in a patient receiving highly active antiretroviral therapy
    Tattevin, Pierre
    Maillard, Anne
    Tribut, Olivier
    Saikali, Emilie
    Arvieux, Cedric
    Michelet, Christian
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2008, 19 (05) : 357 - 358
  • [7] Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy
    Jiménez-Expósito, MJ
    Alonso-Villaverde, C
    Sardà, P
    Masana, L
    [J]. AIDS, 1999, 13 (01) : 152 - 153
  • [8] Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients
    Kumarasamy, N
    Vallabhaneni, S
    Flanigan, TP
    Balakrishnan, P
    Cecelia, A
    Carpenter, CCJ
    Solomon, S
    Mayer, KH
    [J]. AIDS, 2005, 19 (06) : 625 - 627
  • [9] The effectiveness of highly active antiretroviral therapy in HIV-infected patients
    Jensen-Fangel, S
    [J]. DANISH MEDICAL BULLETIN, 2004, 51 (04) : 371 - 392
  • [10] PARKINSONISM IN HIV-INFECTED PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
    Tisch, Stephen
    Brew, Bruce
    [J]. NEUROLOGY, 2009, 73 (05) : 401 - 403